Clinical Trials Logo

Clinical Trial Summary

This is a large-scale, community-based, cross-sectional study to evaluate environmental and genetic risk factors for cardiovascular autonomic neuropathy in general Chinese population.


Clinical Trial Description

A large-scale, community-based, cross-sectional study was conducted to explore the extent to which risk factors associated with cardiovascular autonomic neuropathy (CAN) in general Chinese population. A total of more than 2000 participants were recruited by using multiple stages sampling (first cluster sampling and then simply sampling). Data involved in demographic information, clinical biomarkers such as glucose and lipids profiles, medical and therapy history were collected. Every participants was complete DNA extracted and genotyped. Cardiovascular autonomic functions were measured by using short-term heart rate variability (HRV) to evaluate the outcome of CAN. Univariate and multiple variables analysis have been performed to examine potential environmental and genetic risk factors of CAN. In addition, clinical risk model, simply screening model and non-linear system model such as artificial neural network was created, respectively. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02462616
Study type Observational
Source Shanghai Tongji Hospital, Tongji University School of Medicine
Contact
Status Completed
Phase N/A
Start date January 2011
Completion date December 2016

See also
  Status Clinical Trial Phase
Completed NCT00919347 - The Relative Prevalence and Severity of Autonomic Nervous System Dysfunction N/A
Completed NCT02461342 - Genetic, Environment and Its Interaction Analysis for Cardiovascular Autonomic Neuropathy N/A
Active, not recruiting NCT04625751 - Neurovascular Coupling and Autonomic Neuropathy in Type 2 Diabetes